ArticleActa pharmacologica Sinica2026

BMAL1 silencing as a promising chemosensitizing strategy for triple-negative breast cancer.

Lu-Yi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.